Sharon J. Maples - 13 Jun 2023 Form 4 Insider Report for HESKA CORP

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 13 Jun 2023
Net transaction value: -$1,032,960
SEC form: 4
Accepted by SEC: 14 Jun 2023, 18:27:54 UTC
Prior SEC filing: 06 May 2022
Source filing: View source filing
Reporting owner signature: /s/ By: Catherine Grassman For: Sharon J. Maples

Key filing fact

Sharon J. Maples filed Form 4 for HESKA CORP on 14 Jun 2023.

Key facts

This page summarizes Sharon J. Maples's Form 4 filing for HESKA CORP.
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Jun 2023, 18:27.

Change

Previous filing in this sequence was filed on 06 May 2022.
Current net transaction value: -$1,032,960.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HSKA transaction

Common Stock

Disposed to Issuer

Transaction value: $1,032,960
Shares: -8,608
Change %: -100%
Price: $120.00
Shares after: 0
Date: 13 Jun 2023
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HSKA transaction Derivative

Non-Qualified Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -3,571
Change %: -100%
Price
Shares after: 0
Date: 13 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,571
Exercise price: $39.56
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Sharon J. Maples is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 31, 2023, by and among the Issuer, Antech Diagnostics, Inc., a California corporation ("Acquiror"), Helsinki Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Acquiror, and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation, in exchange for cash consideration of $120.00 per share of common stock of the Issuer (the "Merger Consideration") on the effective date of the merger.

Footnote F2

Stock options of the Issuer were canceled in the merger in exchange for an amount in cash equal to the difference, if any, between the Merger Consideration and the exercise price of such stock options.